Cell & Gene Therapy Manufacturing Services Market Size: Key Players and Market Strategies
The size of Cell & Gene Therapy Manufacturing Services Market was valued at USD 16.92 billion in 2022. It is projected to reach USD 30.86 billion by 2030, with a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2030.
Market Drivers Fueling the Surge:
- Rising Prevalence of Chronic Diseases: The increasing burden of chronic diseases like cancer, neurological disorders, and autoimmune conditions is fueling the demand for cell & gene therapies, which offer potential cures and transformative treatments.
- Technological Advancements: Continuous advancements in cell and gene therapy manufacturing technologies, such as automation, artificial intelligence, and advanced vector production methods, are optimizing processes and improving efficiency, driving market growth.
- Regulatory Landscape: Streamlined regulatory pathways and increased government support for cell & gene therapy research are fostering a more favorable environment for market expansion.
- Shift towards Outsourcing: Pharmaceutical and biotech companies are increasingly outsourcing their cell & gene therapy manufacturing needs to specialized contract manufacturing organizations (CMOs) due to the complex nature of these processes and the need for specialized expertise.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/1187
Market Segmentation Offers Insights:
- By Type: The market is segmented into gene therapy manufacturing and cell therapy manufacturing, with the latter currently holding the larger share due to the wider range of applications.
- By Scale Type: Commercial scale manufacturing is expected to dominate the market as more cell & gene therapies move towards commercialization.
- By Mode Type: Contract manufacturing is anticipated to witness the fastest growth due to its flexibility and cost-effectiveness compared to in-house manufacturing.
- By Workflow Type: Cell processing and fill & finish operations are key workflow segments, with increasing demand for automation and advanced technologies in these areas.
- By Region: North America is currently the largest market, but Asia Pacific is expected to be the fastest-growing region due to its rising healthcare expenditure and supportive government policies.
Key Players and Future Trends:
Leading players in the market include Merck KGaA, Thermo Fisher Scientific, Catalent Inc., Lonza, Takara Bio Inc., Wuxi Advanced Therapies, F. Hoffmann-La Roche Ltd, Samsung Biologics, Bluebird Bio Inc., Novartis AG, Boehringer Ingelheim, Hitachi Chemical Co., Ltd., Miltenyi Biotec, Cellular Therapeutics. The competitive landscape is expected to intensify as more players enter the market, offering diverse capabilities and specialized services.
Emerging trends like personalized medicine, gene editing, and allogeneic cell therapies are expected to further revolutionize the market, creating new opportunities and challenges for players in the cell & gene therapy manufacturing services space.
Other Reports You May Like:
Healthcare/Medical Simulation Market
Healthcare IT Integration Market
Healthcare Interoperability Solutions Market
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian